September 25, 2016 8:41 PM ET

Capital Markets

Company Overview of Sanofi-Genzyme BioVentures

Company Overview

Sanofi-Genzyme BioVentures is a venture capital arm of Genzyme Corp. specializing in investments in growth capital. It only invests in early-stage life science companies. The firm prefers to invest in private biotech and healthcare companies; including rare diseases, oncology, vaccines, integrated health solutions and therapies. It prefers to invest globally with a focus on North America and Europe. The firm typically invests less than or equal to $5 million in a single round of financing and a maximum of $10 million in a single portfolio company for an equity ownership of less than 20 percent. It prefers to have an advisory committee membership, board observer or director positions or SAB m...

Genzyme Center

500 Kendall Street

Cambridge, MA 02142

United States

Founded in 2001

Phone:

617-252-7500

Fax:

617-252-7600

Key Executives for Sanofi-Genzyme BioVentures

Vice President and Managing Director
Age: 56
Senior Director of Investments and Principal
Senior Director of Investments and Principal
Compensation as of Fiscal Year 2016.

Sanofi-Genzyme BioVentures Key Developments

Sanofi-Genzyme BioVentures Presents at BioEquity Europe 2016 Conference, May-10-2016 03:30 PM

Sanofi-Genzyme BioVentures Presents at BioEquity Europe 2016 Conference, May-10-2016 03:30 PM. Venue: Scandic Hotel, Vester Soegade 6, 1601 Copenhagen, Denmark. Speakers: Bernard Davitian, Vice President and Managing Director.

Sanofi-Genzyme BioVentures Presents at BBC BD Boston, Mar-09-2016 10:30 AM

Sanofi-Genzyme BioVentures Presents at BBC BD Boston, Mar-09-2016 10:30 AM. Venue: The Westin Copley Place, 10 Huntington Avenue, Boston, MA 02116, United States. Speakers: Jason P. Hafler, Senior Director of Investments and Principal.

Sanofi-Genzyme BioVentures Presents at Boston Biotech East West CEO Conference, Jan-09-2016 10:25 AM

Sanofi-Genzyme BioVentures Presents at Boston Biotech East West CEO Conference, Jan-09-2016 10:25 AM. Venue: Four Seasons Hotel, 757 Market St., San Francisco, CA 94103, United States. Speakers: Jason P. Hafler, Senior Director of Investments and Principal.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
123Jump.com, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 3, 2016
Common Sensing Inc.
Private Placement
March 30, 2016
Immunexcite, Inc.
Private Placement
February 8, 2016
Yumanity Therapeutics Inc.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sanofi-Genzyme BioVentures, please visit www.genzyme.com/corp/licensing/genzyme_ventures.asp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.